Related Experiment Videos
Radioisotope guided pelvic lymph node dissection for prostate cancer
F Wawroschek1, H Vogt, D Weckermann
1Department of Urology, Zentralklinikum Augsburg, Augsburg, Germany.
The Journal of Urology
|October 5, 2001
Summary
Sentinel lymph node identification using gamma probe technology improves detection of prostate cancer metastasis. This technique offers higher sensitivity than traditional methods for identifying micrometastases.
Area of Science:
- Urology
- Oncology
- Nuclear Medicine
Background:
- Prostate cancer lymph node metastasis detection is challenging.
- Standard pelvic lymphadenectomy may miss micrometastases.
- Sentinel lymph node biopsy (SLNB) shows promise in other cancers.
Purpose of the Study:
- Evaluate the feasibility of SLNB in prostate cancer.
- Compare SLNB sensitivity to modified pelvic lymphadenectomy.
- Assess lymphatic drainage patterns in prostate cancer.
Main Methods:
- 117 patients underwent transrectal injection of 99mtechnetium nanocolloid.
- Dynamic lymphoscintigraphy and gamma probe guided sentinel lymph node removal.
- Subsequent modified pelvic lymphadenectomy was performed.
Main Results:
- Sentinel lymph node identification achieved 96% sensitivity for micrometastasis detection.
- Modified pelvic lymphadenectomy sensitivity was 81.5%.
- 16 patients had positive sentinel nodes only, highlighting their importance.
Conclusions:
- Sentinel lymph node identification is feasible in prostate cancer.
- This technique enhances detection of lymph node metastases.
- Understanding individual lymphatic drainage is crucial for accurate staging.